HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More

This article was originally published in The Rose Sheet

Executive Summary

At its Sept. 11-12 meeting in Washington, the Cosmetic Ingredient Review Expert Panel finalized reports for various protein and peptide ingredient families, among others, and advanced six tentative reports. The panel issued a tentative insufficient data conclusion for broad-spectrum preservative polyaminopropyl biguanide, with concerns about sensitization continuing to weigh on the group.

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS121207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel